Asplenia future or investigational therapies: Difference between revisions
Jump to navigation
Jump to search
Homa Najafi (talk | contribs) No edit summary |
m Bot: Removing from Primary care |
||
Line 9: | Line 9: | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
| |||
{{WikiDoc Help Menu}} | |||
{{WikiDoc Sources}} | |||
[[Category:Medicine]] | [[Category:Medicine]] | ||
[[Category:Oncology]] | [[Category:Oncology]] | ||
[[Category:Up-To-Date | [[Category:Up-To-Date]] | ||
[[Category:Immunology]] | [[Category:Immunology]] | ||
[[Category:Hematology]] | [[Category:Hematology]] | ||
[[Category:Emergency medicine]] | [[Category:Emergency medicine]] | ||
Revision as of 20:29, 29 July 2020
Asplenia Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Asplenia future or investigational therapies On the Web |
American Roentgen Ray Society Images of Asplenia future or investigational therapies |
Risk calculators and risk factors for Asplenia future or investigational therapies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Anum Dilip, M.B.B.S[2]
Overview
Future or Investigational Therapies
References